AR014877A1 - Composiciones y metodos para inhibir el fotoenvejecimiento de la piel - Google Patents
Composiciones y metodos para inhibir el fotoenvejecimiento de la pielInfo
- Publication number
- AR014877A1 AR014877A1 ARP980102601A ARP980102601A AR014877A1 AR 014877 A1 AR014877 A1 AR 014877A1 AR P980102601 A ARP980102601 A AR P980102601A AR P980102601 A ARP980102601 A AR P980102601A AR 014877 A1 AR014877 A1 AR 014877A1
- Authority
- AR
- Argentina
- Prior art keywords
- compositions
- inhibit
- methods
- skin
- photo aging
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 7
- 206010051246 Photodermatosis Diseases 0.000 title abstract 2
- 230000008845 photoaging Effects 0.000 title abstract 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 abstract 2
- 239000004615 ingredient Substances 0.000 abstract 2
- 230000005855 radiation Effects 0.000 abstract 2
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 abstract 1
- 229940124761 MMP inhibitor Drugs 0.000 abstract 1
- 239000004098 Tetracycline Substances 0.000 abstract 1
- 229960004308 acetylcysteine Drugs 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 150000004492 retinoid derivatives Chemical class 0.000 abstract 1
- 230000036561 sun exposure Effects 0.000 abstract 1
- 235000019364 tetracycline Nutrition 0.000 abstract 1
- 150000003522 tetracyclines Chemical class 0.000 abstract 1
- 229940040944 tetracyclines Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Application Of Or Painting With Fluid Materials (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Laminated Bodies (AREA)
- Paints Or Removers (AREA)
- Surface Treatment Of Optical Elements (AREA)
- Medicinal Preparation (AREA)
Abstract
Se revelan composiciones y métodos para mejorar varios efectos de la radiacion UVA y UVB del sol. Las composiciones incluyen un ingrediente queevita el fotoenvejecimiento por radiacion MED y subMED, como por ejemplo un retinoide, algunas composiciones antioxidantes (por ejemplo N-acetilcisteína) y2-furildioxima, y en forma opcional, otros inhibidores de MMP como las tetraciclinas y/o composiciones que inhiben el metabolismo de los retinoidesmediados por P-450, como por ejemploketaconazol y otros componentes azoles. En el método, la composicion se aplica antes de la exposicion al sol; segun seanlos ingredientes usados en la composicion, la aplicacion debe hacerse entre 7 y 48 horas antes de la exposicion.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4852097P | 1997-06-04 | 1997-06-04 | |
US5797697P | 1997-09-05 | 1997-09-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR014877A1 true AR014877A1 (es) | 2001-04-11 |
Family
ID=26726211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980102601A AR014877A1 (es) | 1997-06-04 | 1998-06-03 | Composiciones y metodos para inhibir el fotoenvejecimiento de la piel |
Country Status (21)
Country | Link |
---|---|
US (3) | US6130254A (es) |
EP (1) | EP0998251A4 (es) |
JP (3) | JP3554339B2 (es) |
KR (1) | KR20010013415A (es) |
CN (1) | CN1259040A (es) |
AR (1) | AR014877A1 (es) |
AU (1) | AU8057398A (es) |
BR (1) | BR9809969A (es) |
CA (2) | CA2292600C (es) |
CO (1) | CO4940361A1 (es) |
EA (1) | EA199901115A1 (es) |
HN (1) | HN1999000158A (es) |
ID (1) | ID20400A (es) |
IL (2) | IL133194A0 (es) |
MA (1) | MA24560A1 (es) |
NO (1) | NO995768L (es) |
NZ (2) | NZ501634A (es) |
PL (1) | PL337531A1 (es) |
TN (1) | TNSN98077A1 (es) |
TW (1) | TWI234467B (es) |
WO (1) | WO1998055075A2 (es) |
Families Citing this family (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU737376B2 (en) * | 1997-02-25 | 2001-08-16 | Regents Of The University Of Michigan, The | Methods and compositions for preventing and treating chronological aging in human skin |
AUPP112497A0 (en) * | 1997-12-24 | 1998-01-22 | Novogen Research Pty Ltd | Compositions and method for protecting skin from UV induced immunosupression and skin damage |
WO2000021925A1 (fr) * | 1998-10-09 | 2000-04-20 | Ajinomoto Co., Inc. | Derives de la cysteine |
US6887260B1 (en) | 1998-11-30 | 2005-05-03 | Light Bioscience, Llc | Method and apparatus for acne treatment |
US6283956B1 (en) | 1998-11-30 | 2001-09-04 | David H. McDaniels | Reduction, elimination, or stimulation of hair growth |
US20060212025A1 (en) | 1998-11-30 | 2006-09-21 | Light Bioscience, Llc | Method and apparatus for acne treatment |
US7268148B2 (en) * | 1999-05-20 | 2007-09-11 | Regents Of The University Of Michigan | Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes |
US20040235950A1 (en) * | 1999-05-20 | 2004-11-25 | Voorhees John J. | Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes |
IN2000KO00299A (es) * | 1999-05-28 | 2005-11-18 | Johnson & Johnson Consumer | |
US20030003170A1 (en) * | 2000-06-02 | 2003-01-02 | Theresa Callaghan | Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium) |
GB9919079D0 (en) * | 1999-08-12 | 1999-10-13 | Clayton Paul R | Skin care product |
FR2805158B1 (fr) * | 2000-02-18 | 2004-12-03 | L M D | Composition cosmetique ou medicamenteuse contenant une lactone sesquiterpenique ou un analogue pour traiter les desordres lies a la croissance pilaire, et son procede de preparation. |
DE10020447A1 (de) * | 2000-03-31 | 2001-10-11 | Henkel Kgaa | Verwendung von Protease-Inhibitoren in der Kosmetik und Pharmazie |
WO2001074320A2 (de) * | 2000-03-31 | 2001-10-11 | Henkel Kommanditgesellschaft Auf Aktien | Verwendung von protease-inhibitoren in der kosmetik und pharmazie |
JP2002080338A (ja) * | 2000-06-20 | 2002-03-19 | Shiseido Co Ltd | 老化防止用皮膚外用剤 |
US20020012641A1 (en) * | 2000-06-26 | 2002-01-31 | Voorhees John J. | Use of EGF-R protein tyrosine kinase inhibitors for preventing photoaging in human skin |
WO2002019982A2 (en) | 2000-06-29 | 2002-03-14 | Quick Med Technologies, Inc. | Cosmetic composition and method for reducing or preventing wrinkling |
US20040185127A1 (en) * | 2001-06-29 | 2004-09-23 | Lerner David S. | Cosmetic composition and method |
EP1296638A2 (en) * | 2000-07-06 | 2003-04-02 | The Regents Of The University Of Michigan | UVA (>360-400) AND UVB (300-325) SPECIFIC SUNSCREENS |
FR2811561B1 (fr) * | 2000-07-13 | 2003-03-21 | Oreal | Composition, notamment cosmetique, renfermant la dhea et/ou un precurseur ou derive chimique ou biologique de celle-ci, et un inhibiteur de metalloproteinase |
EP1191024A1 (en) * | 2000-09-22 | 2002-03-27 | Harald Tschesche | Thiadiazines and their use as inhibitors of metalloproteinases |
FR2815252B1 (fr) * | 2000-10-17 | 2002-12-20 | Oreal | Composition, notamment cosmetique, renfermant du retinol et un compose capable de filtrer le rayonnement uva |
FR2815861B1 (fr) * | 2000-10-26 | 2003-02-28 | Oreal | Utilisation de l'association d'au moins un carotenoide et d'au moins un isoflavonoide pour traiter les signes cutanes du vieillissement |
FR2815859B1 (fr) * | 2000-10-26 | 2003-02-28 | Oreal | Utilisation de l'association d'au moins un carotenoide a activite provitaminique a et d'au moins un carotenoide sans activite provitaminique a pour traiter les signes du vieillissement |
US20020119107A1 (en) * | 2000-12-18 | 2002-08-29 | James Varani | Method for protecting and restoring skin using selective MMP inhibitors |
US20020143059A1 (en) * | 2000-12-28 | 2002-10-03 | Sreekumar Pillai | Skin care product containing retinoids, retinoid booster and phytoestrogens in a dual compartment package |
US20030077343A1 (en) * | 2001-03-16 | 2003-04-24 | Martin Katharine M. | Composition containing feverfew extract and use thereof |
CA2441025C (en) * | 2001-03-16 | 2011-08-16 | Johnson & Johnson Consumer Companies, Inc. | Composition containing feverfew extract and use thereof |
EP1402068A4 (en) * | 2001-05-09 | 2006-07-12 | Univ Cleveland Hospitals | ASSESSMENT OF SKIN INJURY CAUSED BY ULTRAVIOLETTE RADIATION BY MEANS OF NEW GENETIC MARKERS, METHODS AND COMPOSITIONS THEREFOR |
CA2347562A1 (en) * | 2001-05-14 | 2002-11-14 | John Lovaghy | Device for aligning papers flowing in a stream |
FR2826266B1 (fr) * | 2001-06-26 | 2005-02-25 | Oreal | Composition cosmetique ou dermatologique comprenant une association entre un compose de la famille des n-acylaminoamides et au moins un inhibiteur de metalloproteinases matricielles |
US6830746B2 (en) * | 2001-09-21 | 2004-12-14 | Playtex Products, Inc. | Sunscreen compositions |
WO2004043469A1 (en) * | 2001-11-16 | 2004-05-27 | Klysz Beatrice M | Anti-aging skin care composition and uses thereof |
KR100432449B1 (ko) * | 2001-11-30 | 2004-05-22 | 우원홍 | 케토코나졸 함유 피부 미백용 외용제 조성물 |
WO2003063179A1 (fr) * | 2002-01-23 | 2003-07-31 | Allmighty Co., Ltd. | Protection contre les rayonnements et utilisation associee |
JP4575667B2 (ja) | 2002-03-08 | 2010-11-04 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 医薬として有用な大環状化合物 |
DE10214257A1 (de) * | 2002-03-28 | 2003-10-16 | Merck Patent Gmbh | Verwendung von kompatiblen Soluten zur Inhibierung der Freisetzung von Ceramiden |
US7108860B2 (en) * | 2002-06-06 | 2006-09-19 | Playtex Products, Inc. | Sunscreen compositions |
JP2006508058A (ja) * | 2002-09-23 | 2006-03-09 | ノボジェン・リサーチ・プロプライエタリー・リミテッド | 皮膚光老化および光線性損傷の治療 |
EP1594459B1 (en) | 2002-12-30 | 2010-02-17 | Angiotech International Ag | Drug delivery from rapid gelling polymer composition |
JP2006522660A (ja) | 2003-04-10 | 2006-10-05 | ライト バイオサイエンス,エルエルシー | 細胞増殖及び遺伝子発現を調節するためのフォトモジュレーション方法及び装置 |
CN101247768A (zh) * | 2003-07-31 | 2008-08-20 | 莱特生物科学有限公司 | 用于光动力学治疗烧伤、创伤和相关皮肤病的***和方法 |
FR2861293B1 (fr) * | 2003-10-22 | 2008-10-17 | Greenpharma Sas | Composition pour prevenir ou traiter des affections resultant d'un processus de mort cellulaire comprenant une lactone sesquiterpenique |
EP2233127B1 (de) | 2004-03-17 | 2020-05-27 | Stada Arzneimittel Ag | Verwendung von Antioxidantien zur Herstellung einer pharmazeutischen oder kosmetischen Zusammensetzung zum Schutz der Haut gegen Schädigung durch Infrarot-Strahlung |
US7449203B2 (en) * | 2004-06-30 | 2008-11-11 | E-L Management Corporation | Cosmetic compositions and methods comprising Rhodiola rosea |
EP2377532A1 (en) | 2004-08-18 | 2011-10-19 | Ace ApS | Cosmetic and pharmaceutical compositions comprising ACE inhibitors and/or angiotensin II receptor antagonists for treating dermatological disorders |
JP4777738B2 (ja) * | 2004-10-14 | 2011-09-21 | 株式会社 資生堂 | Adam活性阻害物質によるしわの防止または改善 |
US20060265030A1 (en) * | 2004-11-12 | 2006-11-23 | Light Bioscience, Llc | System and method for photodynamic cell therapy |
JP4546228B2 (ja) * | 2004-12-02 | 2010-09-15 | 株式会社資生堂 | 経皮吸収促進用油性皮膚外用組成物 |
US20060286046A1 (en) * | 2005-01-05 | 2006-12-21 | Haber C Andrew | Skin care compositions |
FR2885804A1 (fr) * | 2005-05-17 | 2006-11-24 | Engelhard Corp | Compositions de soins pour la peau, produits les contenant et procedes les utilisant |
US20060292094A1 (en) * | 2005-06-24 | 2006-12-28 | Robert Bell | Composition and method of protection against UV irradiation |
EP1940816A2 (en) * | 2005-09-30 | 2008-07-09 | OMP, Inc. | Stable ascorbic acid compositions |
RU2423974C2 (ru) * | 2005-10-20 | 2011-07-20 | ЭПИФАРМ ГмбХ | Лечение и профилактика доброкачественных пигментных пятен (невусов) с помощью артемизинина и его производных |
US20070178058A1 (en) * | 2006-02-02 | 2007-08-02 | Ramirez Jose E | Methods of using stable ascorbic acid compositions |
US20070269534A1 (en) * | 2006-02-02 | 2007-11-22 | Ramirez Jose E | Methods of treating skin to enhance therapeutic treatment thereof |
US20080014156A1 (en) * | 2006-07-12 | 2008-01-17 | Horn Gregory T | Photoprotectant composition for preventing sunburn and sun damage to the skin |
US20080025930A1 (en) * | 2006-07-31 | 2008-01-31 | Hugo Corstjens | Anti-aging Compositions Comprising Menyanthes Trifoliata Leaf Extracts and Methods of Use Thereof |
WO2008036979A2 (en) * | 2006-09-22 | 2008-03-27 | Guilford F Timothy | Topical application of melatonin directly or in liposomes for the amelioration of itching and histamine and non-histamine related inflammatory skin changes |
WO2008134712A2 (en) * | 2007-04-30 | 2008-11-06 | Living Proof, Inc. | Use of matrix metalloproteinase inhibitors in skin care |
FR2924334B1 (fr) * | 2007-11-30 | 2016-03-25 | Lvmh Rech | Composition cosmetique comprenant l'acide 2-glucoside ascorbique et l'ergothioneine. |
US20110177014A1 (en) * | 2008-04-01 | 2011-07-21 | Biopharmacopae Design International Inc. | Extracts from plants of the tsuga genus and uses thereof in the treatment of inflammation, irritation and/or infection |
NZ593932A (en) * | 2009-01-05 | 2013-11-29 | Ernest T Armstrong | Vitamin d promoting sunscreen |
US8080265B2 (en) * | 2009-02-20 | 2011-12-20 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating signs of skin aging |
US20110150856A1 (en) | 2009-12-21 | 2011-06-23 | Sarah Bacus | Compositions and methods for treatment of vitiligo |
US20110150798A1 (en) * | 2009-12-21 | 2011-06-23 | Sarah Bacus | Compositions and methods for increasing cellular far and bleaching skin |
US8435541B2 (en) | 2010-09-02 | 2013-05-07 | Bath & Body Works Brand Management, Inc. | Topical compositions for inhibiting matrix metalloproteases and providing antioxidative activities |
JP4927206B2 (ja) * | 2010-09-17 | 2012-05-09 | 株式会社ファンケル | コラーゲン産生促進剤、ヒアルロン酸産生促進剤、しわ改善剤 |
JP2012056951A (ja) * | 2011-09-30 | 2012-03-22 | Maruzen Pharmaceut Co Ltd | 皮膚化粧料並びに飲食品 |
ES2378028B1 (es) * | 2012-02-22 | 2013-02-18 | Ignacio Umbert Millet | Composición cosmética para el rejuvenecimiento de la piel y procedimiento y usos correspondientes |
KR20170086678A (ko) * | 2012-05-21 | 2017-07-26 | 디씨비-유에스에이 엘엘씨 | 제브라피시 모델을 사용한 약물 스크리닝 방법 및 이 방법으로 스크린된 화합물 |
EP2934555B1 (en) | 2012-12-21 | 2021-09-22 | Astellas Institute for Regenerative Medicine | Methods for production of platelets from pluripotent stem cells |
US9144538B2 (en) | 2013-02-08 | 2015-09-29 | The Procter & Gamble Company | Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin |
US9138393B2 (en) | 2013-02-08 | 2015-09-22 | The Procter & Gamble Company | Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin |
JP5768113B2 (ja) * | 2013-11-29 | 2015-08-26 | ポーラ化成工業株式会社 | 前処置用の皮膚外用剤の製造方法 |
US10058542B1 (en) | 2014-09-12 | 2018-08-28 | Thioredoxin Systems Ab | Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith |
KR20160118550A (ko) | 2015-04-02 | 2016-10-12 | 계명대학교 산학협력단 | 초석잠 추출물을 유효성분으로 함유하는 광조사에 의한 피부 세포손상 예방 또는 치료용 약학조성물 |
WO2017067545A1 (de) | 2015-10-20 | 2017-04-27 | Laser- Und Medizin-Technologie Gmbh, Berlin | Optische ermittlung der schutzfaktoren von sonnenschutz- bzw. anderen strahlungsschutzmitteln |
JP2017210442A (ja) * | 2016-05-26 | 2017-11-30 | イノレックス インベストメント コーポレイション | マトリックスメタロプロテイナーゼを阻害して皮膚の老化を軽減する方法及び関連の相乗的組成物 |
KR101882736B1 (ko) * | 2017-07-10 | 2018-07-27 | 김삼 | 멜라토닌, 비타민 c 및 피크노제놀을 유효 성분으로 함유한 피부보호용 조성물 |
US11344497B1 (en) | 2017-12-08 | 2022-05-31 | Quicksilver Scientific, Inc. | Mitochondrial performance enhancement nanoemulsion |
US10722465B1 (en) | 2017-12-08 | 2020-07-28 | Quicksilber Scientific, Inc. | Transparent colloidal vitamin supplement |
JP2018168177A (ja) * | 2018-07-03 | 2018-11-01 | イノレックス インベストメント コーポレイション | マトリックスメタロプロテイナーゼを阻害して皮膚の老化を軽減する方法及び関連の相乗的組成物 |
US20220016006A1 (en) * | 2018-12-05 | 2022-01-20 | RepoCeuticals A/S | Compositions for use in the treatment of photosensitivity |
US11291702B1 (en) | 2019-04-15 | 2022-04-05 | Quicksilver Scientific, Inc. | Liver activation nanoemulsion, solid binding composition, and toxin excretion enhancement method |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4877805A (en) * | 1985-07-26 | 1989-10-31 | Kligman Albert M | Methods for treatment of sundamaged human skin with retinoids |
JPS58181041A (ja) * | 1982-04-16 | 1983-10-22 | Fuji Photo Film Co Ltd | ハロゲン化銀写真感光材料 |
FR2528420A1 (fr) * | 1982-06-15 | 1983-12-16 | Oreal | Nouveaux 3-benzylidene camphres, leur procede de preparation et leur utilisation pour la protection contre les rayons uv |
LU85556A1 (fr) * | 1984-09-26 | 1986-04-03 | Cird | Nouveaux derives de l'acide retinoique,leur procede de preparation et compositions medicamenteuse et cosmetique les contenant |
US4885282A (en) * | 1987-07-02 | 1989-12-05 | Thornfeldt Carl R | Treatment of hyperhidrosis, ichthyosis and wrinkling |
US5260059A (en) * | 1989-04-14 | 1993-11-09 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon Health Sciences University | Treatment of open-angle glaucoma by modulation matrix metalloproteinases and their inhibitor |
US5002760A (en) * | 1989-10-02 | 1991-03-26 | Katzev Phillip K | Retinol skin care composition |
EP0611301B1 (en) * | 1990-04-26 | 2003-06-11 | The Procter & Gamble Company | Chelator compositions comprising oxime compounds |
US5073372A (en) * | 1990-11-30 | 1991-12-17 | Richardson-Vicks, Inc. | Leave-on facial emulsion compositions |
GB9109733D0 (en) | 1991-05-07 | 1991-06-26 | Unilever Plc | Cosmetic composition |
US5296500A (en) * | 1991-08-30 | 1994-03-22 | The Procter & Gamble Company | Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy |
WO1993010755A1 (en) * | 1991-11-25 | 1993-06-10 | Richardson-Vicks, Inc. | Compositions for regulating skin wrinkles and/or skin atrophy |
US5629365A (en) * | 1992-06-23 | 1997-05-13 | Monsanto Company | UV-absorbing polymer latex |
BR9306816A (pt) * | 1992-07-28 | 1998-12-08 | Procter & Gamble | Composição farmaceutica para uso tópico contendo um polímero catiônico reticulado e um eter alcoxilado |
DE4305788C2 (de) * | 1993-02-25 | 1997-06-12 | Beiersdorf Ag | Kosmetische und dermatologische Formulierungen zum Schutze der Haut gegen Oxidationsprozesse |
GB9223235D0 (en) | 1992-11-05 | 1992-12-16 | Unilever Plc | Cosmetic composition |
US5612215A (en) * | 1992-12-07 | 1997-03-18 | Ribozyme Pharmaceuticals, Inc. | Stromelysin targeted ribozymes |
DE4242876C2 (de) * | 1992-12-18 | 1997-11-27 | Beiersdorf Ag | Kosmetische und/oder dermatologische Zubereitungen zur kosmetischen und/oder dermatologischen Pflege der Haut und/oder der Hautanhangsgebilde |
US5459332A (en) * | 1994-03-31 | 1995-10-17 | The United States Of America As Represented By The Secretary Of The Navy | Semiconductor photodetector device |
EP0754039A4 (en) | 1994-04-08 | 2002-07-17 | Procter & Gamble | METHODS OF USING IRON-CONTAINING CHELATES TO REDUCE MAMMALIAN FREE RADICAL DAMAGES |
WO1996007396A2 (en) * | 1994-09-07 | 1996-03-14 | Johnson & Johnson Consumer Products, Inc. | Retinoid compositions |
US6153176A (en) * | 1995-01-20 | 2000-11-28 | The Procter & Gamble Company | Low pH sunscreen compositions |
US5618522A (en) * | 1995-01-20 | 1997-04-08 | The Procter & Gamble Company | Emulsion compositions |
EP0806947A4 (en) * | 1995-02-03 | 1998-10-14 | Cosmederm Technologies | FORMULATIONS AND METHODS FOR REDUCING SKIN IRRITATION |
US5609854A (en) * | 1995-06-06 | 1997-03-11 | Elizabeth Arden Company, Division Of Conopco, Inc. | Thickened and stabilized cosmetic emulsion compositions |
EP0831766B2 (en) * | 1995-06-08 | 2009-11-11 | Johnson & Johnson Consumer Companies, Inc. | Sunscreen compositions |
US5837224A (en) * | 1996-01-19 | 1998-11-17 | The Regents Of The University Of Michigan | Method of inhibiting photoaging of skin |
US5824702A (en) * | 1996-06-07 | 1998-10-20 | Mount Sinai School Of Medicine Of The City University Of New York | Genistein as a preventive against ultraviolet induced skin photodamage and cancer |
US5916910A (en) * | 1997-06-04 | 1999-06-29 | Medinox, Inc. | Conjugates of dithiocarbamates with pharmacologically active agents and uses therefore |
-
1998
- 1998-05-26 TW TW087108160A patent/TWI234467B/zh not_active IP Right Cessation
- 1998-06-02 CO CO98030959A patent/CO4940361A1/es unknown
- 1998-06-03 AR ARP980102601A patent/AR014877A1/es unknown
- 1998-06-03 BR BR9809969-8A patent/BR9809969A/pt not_active IP Right Cessation
- 1998-06-03 JP JP50283399A patent/JP3554339B2/ja not_active Expired - Fee Related
- 1998-06-03 IL IL13319498A patent/IL133194A0/xx unknown
- 1998-06-03 CN CN98805763A patent/CN1259040A/zh active Pending
- 1998-06-03 AU AU80573/98A patent/AU8057398A/en not_active Abandoned
- 1998-06-03 EP EP98928879A patent/EP0998251A4/en not_active Ceased
- 1998-06-03 NZ NZ501634A patent/NZ501634A/en not_active IP Right Cessation
- 1998-06-03 US US09/089,914 patent/US6130254A/en not_active Expired - Lifetime
- 1998-06-03 NZ NZ513045A patent/NZ513045A/xx not_active IP Right Cessation
- 1998-06-03 EA EA199901115A patent/EA199901115A1/ru unknown
- 1998-06-03 TN TNTNSN98077A patent/TNSN98077A1/fr unknown
- 1998-06-03 WO PCT/US1998/011453 patent/WO1998055075A2/en not_active Application Discontinuation
- 1998-06-03 PL PL98337531A patent/PL337531A1/xx unknown
- 1998-06-03 MA MA25097A patent/MA24560A1/fr unknown
- 1998-06-03 CA CA002292600A patent/CA2292600C/en not_active Expired - Fee Related
- 1998-06-03 KR KR19997011416A patent/KR20010013415A/ko not_active Application Discontinuation
- 1998-06-03 CA CA2601462A patent/CA2601462C/en not_active Expired - Fee Related
- 1998-06-04 ID IDP980822A patent/ID20400A/id unknown
-
1999
- 1999-09-10 HN HN1999000158A patent/HN1999000158A/es unknown
- 1999-11-25 NO NO995768A patent/NO995768L/no not_active Application Discontinuation
- 1999-11-29 IL IL133194A patent/IL133194A/en not_active IP Right Cessation
-
2000
- 2000-07-13 US US09/615,218 patent/US6365630B1/en not_active Expired - Lifetime
-
2002
- 2002-03-15 JP JP2002071908A patent/JP2003034137A/ja active Pending
- 2002-04-02 US US10/114,651 patent/US6942870B2/en not_active Expired - Lifetime
-
2004
- 2004-03-24 JP JP2004087496A patent/JP2004217670A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU8057398A (en) | 1998-12-21 |
IL133194A0 (en) | 2001-03-19 |
NZ501634A (en) | 2001-09-28 |
CA2292600A1 (en) | 1998-12-10 |
CO4940361A1 (es) | 2000-07-24 |
CA2292600C (en) | 2007-11-27 |
JP2003034137A (ja) | 2003-02-04 |
CA2601462A1 (en) | 1998-12-10 |
WO1998055075A2 (en) | 1998-12-10 |
EP0998251A2 (en) | 2000-05-10 |
JP2001520677A (ja) | 2001-10-30 |
NZ513045A (en) | 2002-10-25 |
US20020106339A1 (en) | 2002-08-08 |
CN1259040A (zh) | 2000-07-05 |
JP2004217670A (ja) | 2004-08-05 |
KR20010013415A (ko) | 2001-02-26 |
MA24560A1 (fr) | 1998-12-31 |
EP0998251A4 (en) | 2000-08-30 |
WO1998055075A3 (en) | 1999-06-17 |
US6365630B1 (en) | 2002-04-02 |
NO995768L (no) | 2000-01-17 |
IL133194A (en) | 2009-05-04 |
US6942870B2 (en) | 2005-09-13 |
HN1999000158A (es) | 2001-03-06 |
TWI234467B (en) | 2005-06-21 |
EA199901115A1 (ru) | 2000-06-26 |
TNSN98077A1 (fr) | 2005-03-15 |
NO995768D0 (no) | 1999-11-25 |
JP3554339B2 (ja) | 2004-08-18 |
PL337531A1 (en) | 2000-08-28 |
BR9809969A (pt) | 2000-10-17 |
CA2601462C (en) | 2011-03-15 |
US6130254A (en) | 2000-10-10 |
ID20400A (id) | 1998-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR014877A1 (es) | Composiciones y metodos para inhibir el fotoenvejecimiento de la piel | |
ES2107762T3 (es) | Utilizacion de un alquilester de glutation en una composicion cosmetica o dermatologica destinada al tratamiento por via topica del envejecimiento cutaneo. | |
AR047513A1 (es) | Metodos y composiciones para el tratamiento de cambios en la piel relacionados con el envejecimiento y los danos ocasionados por el medio ambiente | |
ES2126790T3 (es) | Composicion cosmetica que comprende una hidrocalcona y retinol o un derivado de este. | |
ES2181376T3 (es) | Composicion cosmetica y/o dermatologica que contiene acido salicilico o un derivado del acido salicilico y su utilizacion. | |
AR005650A1 (es) | Metodo para inhibir el fotoenvejecimiento de la piel humana no danada por la radiacion uvb mediante inhibidores de la sintesis y/o actividad de mmp y lautilizacion de dichos inhibidores en la preparacion de medicamentos para prevenir dicho envejecimiento. | |
DK1259218T3 (da) | Kosmetisk sammensætning til behandling af aldrende og/eller stresset hud | |
AR006800A1 (es) | Una composición para el tratamiento cosmético de la piel, y un método de tratamiento cosmético de la piel. | |
ES2185155T3 (es) | Agentes conservantes de madera para la proteccion subsiguiente. | |
SV2004001373A (es) | Inhibidores de pde9 para tratamiento de transtornos cardiovasculares. ref. pcs22051 | |
CR7716A (es) | Uso de inhibidores de la ikb-quinasa para el tratamiento del dolor | |
BR0211390A (pt) | Tratamento de infecções da unha com no | |
CY1106064T1 (el) | Τυποποιηση ενος εστερα τεστοστepονης για ανθρωπινη χρηση | |
AR009098A1 (es) | Una composicion para el acondicionamiento de la piel y metodos cosmeticos que comprenden la aplicacion sobre la piel de dicha composicion | |
ES2185241T3 (es) | Utilizacion de composiciones cosmeticas que contienen al menos una uxina. | |
ES2146269T3 (es) | Composicion cosmetica para la piel. | |
ES2164484T3 (es) | Composicion cosmetica que contiene un poliorganosiloxano y un terpolimero acrilico y utilizacion de esta composicion para el tratamiento de materias queratinicas. | |
AR026490A1 (es) | Composiciones cosmeticas que contienen extracto de garbanzo en combinacion con retinoides y metodo cosmetico de aplicacion de dicha composicion | |
ES2122241T3 (es) | Uso de un diterpeno fenolico para fabricar una composicion para uso terapeutico sobre la piel. | |
ES2077549T1 (es) | Composiciones dermatologicas que contienen derivados de estilbeno para la proteccion frente a la radiacion uv. | |
AR006801A1 (es) | Una composicion para el acondicionamiento de la piel que contiene melinamida , retinol y/o ester de retinilo, y un metodo cosmetico no terapeutico para el acondicionamiento de la piel que comprende la aplicacion de dicha composicion. | |
BR0112355A (pt) | Uso de inibidores da proteìna egf-r tirosina cinase para a prevenção do fotoenvelhecimento da pele humana | |
MX9201170A (es) | Composicion cosmetica para luchar contra el envejecimiento de la piel, que contiene en asociacion al menos un retinoide y al menos una dialquilo trialquilxantina. | |
ES2196737T3 (es) | Asociacion de un retinoide con un derivado de histidina. | |
AR003758A1 (es) | Composicion cosmetica para uso topico, en particular para la fotoproteccion de la piel y/o de los cabellos, procedimiento de tratamiento cosmetico que laemplea, utilizacion de un acilaminoacido en una composicion que contiene pigmentos de oxido de titanio y procedimiento para reducir el fotoazulamiento |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |